CFTR and cystic fibrosis: Altogether, it is clear that multiple cell types contribute to the hyper-inflammatory phenotype observed throughout multiple organs in CF, requiring a broad therapeutic approach that allows correcting the multiple innate immune defects associated with dysfunctional CFTR.